Preliminary study on early diagnosis of Alzheimer’s disease in APP/PS1 transgenic mice using multimodal magnetic resonance imaging

Alzheimer’s disease (AD) has an insidious onset and lacks clear early diagnostic markers, and by the time overt dementia symptoms appear, the disease is already in the mid-to-late stages. The search for early diagnostic markers of AD may open a critical window for Alzheimer’s treatment and facilitat...

Full description

Bibliographic Details
Main Authors: Meng Xu, Jipeng Liu, Qingguo Liu, Yu Gong, Yinyin Li, Jing Zhang, Shufeng Shi, Yuanyuan Shi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Aging Neuroscience
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2024.1326394/full
_version_ 1797311678041292800
author Meng Xu
Meng Xu
Jipeng Liu
Qingguo Liu
Yu Gong
Yinyin Li
Yinyin Li
Jing Zhang
Shufeng Shi
Yuanyuan Shi
Yuanyuan Shi
Yuanyuan Shi
author_facet Meng Xu
Meng Xu
Jipeng Liu
Qingguo Liu
Yu Gong
Yinyin Li
Yinyin Li
Jing Zhang
Shufeng Shi
Yuanyuan Shi
Yuanyuan Shi
Yuanyuan Shi
author_sort Meng Xu
collection DOAJ
description Alzheimer’s disease (AD) has an insidious onset and lacks clear early diagnostic markers, and by the time overt dementia symptoms appear, the disease is already in the mid-to-late stages. The search for early diagnostic markers of AD may open a critical window for Alzheimer’s treatment and facilitate early intervention to slow the progression of AD. In this study, we aimed to explore the imaging markers for early diagnosis of AD through the combined application of structural magnetic resonance imaging (sMRI), resting-state functional magnetic resonance imaging (rs-fMRI), and 1H-magnetic resonance spectroscopy (1H-MRS) multimodal magnetic resonance imaging (MRI) techniques at the animal experimental level, with the aim to provide a certain reference for early clinical diagnosis of AD. First, sMRI scans were performed on 4-month-old amyloid beta precursor protein/presenilin 1 (APP/PS1) transgenic AD model mice and wild type mice of the same litter using a 7.0 T animal MRI scanner to analyze the differential brain regions with structural changes in the gray matter of the brain by voxel-based morphometry (VBM). Next, rs-fMRI scans were performed to analyze the differential brain regions between groups for local spontaneous brain activity and functional connectivity (FC) between brain regions. Finally, 1H-MRS scans were performed to quantify and analyze intergroup differences in the relative concentrations of different metabolites within regions of interest (cortex and hippocampus). Compared with wild type mice, the volume of the left hippocampus, and right olfactory bulb of APP/PS1 transgenic AD model mice were reduced, the functional activity of the bilateral hippocampus, right piriform cortex and right caudate putamen was reduced, the functional network connectivity of the hippocampus was impaired, and the relative content of N-acetylaspartate (NAA)in the hippocampus was decreased. In addition, this study found that imaging changes in olfactory-related brain regions were closely associated with AD diagnosis, and these findings may provide some reference for the early diagnosis of AD.
first_indexed 2024-03-08T02:03:10Z
format Article
id doaj.art-d703ff6f867b459fb7b97c0ca8d0bcd8
institution Directory Open Access Journal
issn 1663-4365
language English
last_indexed 2024-03-08T02:03:10Z
publishDate 2024-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Aging Neuroscience
spelling doaj.art-d703ff6f867b459fb7b97c0ca8d0bcd82024-02-14T04:41:35ZengFrontiers Media S.A.Frontiers in Aging Neuroscience1663-43652024-02-011610.3389/fnagi.2024.13263941326394Preliminary study on early diagnosis of Alzheimer’s disease in APP/PS1 transgenic mice using multimodal magnetic resonance imagingMeng Xu0Meng Xu1Jipeng Liu2Qingguo Liu3Yu Gong4Yinyin Li5Yinyin Li6Jing Zhang7Shufeng Shi8Yuanyuan Shi9Yuanyuan Shi10Yuanyuan Shi11Department of Tuina, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, ChinaSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, ChinaSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, ChinaSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, ChinaSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, ChinaSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, ChinaDepartment Shenzhen Hospital (Longgang), Beijing University of Chinese Medicine, Shenzhen, ChinaSchool of Acupuncture-Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, ChinaDepartment of Tuina, Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, ChinaSchool of Life Sciences, Beijing University of Chinese Medicine, Beijing, ChinaShenzhen Research Institute, Beijing University of Chinese Medicine, Shenzhen, ChinaShenzhen Cell Valley Biopharmaceuticals Co., Ltd., Shenzhen, ChinaAlzheimer’s disease (AD) has an insidious onset and lacks clear early diagnostic markers, and by the time overt dementia symptoms appear, the disease is already in the mid-to-late stages. The search for early diagnostic markers of AD may open a critical window for Alzheimer’s treatment and facilitate early intervention to slow the progression of AD. In this study, we aimed to explore the imaging markers for early diagnosis of AD through the combined application of structural magnetic resonance imaging (sMRI), resting-state functional magnetic resonance imaging (rs-fMRI), and 1H-magnetic resonance spectroscopy (1H-MRS) multimodal magnetic resonance imaging (MRI) techniques at the animal experimental level, with the aim to provide a certain reference for early clinical diagnosis of AD. First, sMRI scans were performed on 4-month-old amyloid beta precursor protein/presenilin 1 (APP/PS1) transgenic AD model mice and wild type mice of the same litter using a 7.0 T animal MRI scanner to analyze the differential brain regions with structural changes in the gray matter of the brain by voxel-based morphometry (VBM). Next, rs-fMRI scans were performed to analyze the differential brain regions between groups for local spontaneous brain activity and functional connectivity (FC) between brain regions. Finally, 1H-MRS scans were performed to quantify and analyze intergroup differences in the relative concentrations of different metabolites within regions of interest (cortex and hippocampus). Compared with wild type mice, the volume of the left hippocampus, and right olfactory bulb of APP/PS1 transgenic AD model mice were reduced, the functional activity of the bilateral hippocampus, right piriform cortex and right caudate putamen was reduced, the functional network connectivity of the hippocampus was impaired, and the relative content of N-acetylaspartate (NAA)in the hippocampus was decreased. In addition, this study found that imaging changes in olfactory-related brain regions were closely associated with AD diagnosis, and these findings may provide some reference for the early diagnosis of AD.https://www.frontiersin.org/articles/10.3389/fnagi.2024.1326394/fullAlzheimer’s diseaseAPP/PS1 transgenic miceearly diagnosissMRIrs-fMRI1H-MRS
spellingShingle Meng Xu
Meng Xu
Jipeng Liu
Qingguo Liu
Yu Gong
Yinyin Li
Yinyin Li
Jing Zhang
Shufeng Shi
Yuanyuan Shi
Yuanyuan Shi
Yuanyuan Shi
Preliminary study on early diagnosis of Alzheimer’s disease in APP/PS1 transgenic mice using multimodal magnetic resonance imaging
Frontiers in Aging Neuroscience
Alzheimer’s disease
APP/PS1 transgenic mice
early diagnosis
sMRI
rs-fMRI
1H-MRS
title Preliminary study on early diagnosis of Alzheimer’s disease in APP/PS1 transgenic mice using multimodal magnetic resonance imaging
title_full Preliminary study on early diagnosis of Alzheimer’s disease in APP/PS1 transgenic mice using multimodal magnetic resonance imaging
title_fullStr Preliminary study on early diagnosis of Alzheimer’s disease in APP/PS1 transgenic mice using multimodal magnetic resonance imaging
title_full_unstemmed Preliminary study on early diagnosis of Alzheimer’s disease in APP/PS1 transgenic mice using multimodal magnetic resonance imaging
title_short Preliminary study on early diagnosis of Alzheimer’s disease in APP/PS1 transgenic mice using multimodal magnetic resonance imaging
title_sort preliminary study on early diagnosis of alzheimer s disease in app ps1 transgenic mice using multimodal magnetic resonance imaging
topic Alzheimer’s disease
APP/PS1 transgenic mice
early diagnosis
sMRI
rs-fMRI
1H-MRS
url https://www.frontiersin.org/articles/10.3389/fnagi.2024.1326394/full
work_keys_str_mv AT mengxu preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging
AT mengxu preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging
AT jipengliu preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging
AT qingguoliu preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging
AT yugong preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging
AT yinyinli preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging
AT yinyinli preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging
AT jingzhang preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging
AT shufengshi preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging
AT yuanyuanshi preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging
AT yuanyuanshi preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging
AT yuanyuanshi preliminarystudyonearlydiagnosisofalzheimersdiseaseinappps1transgenicmiceusingmultimodalmagneticresonanceimaging